FDA approves Takeda's metastatic colorectal cancer drug
A small molecule, oral targeted therapy for adults with metastatic colorectal cancer (CRC) has been approved by the US Food and Drug Administration (FDA).
Archives for November 13, 2023
Interview: Phenomix' Mark Bagnall and obesity's four different phenotypes
Ever since injections promising to help people lose weight hit the shelves, interest around the world has been phenomenal. So high was demand, companies were finding it difficult to keep up with the demand.